基本信息
views: 319
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Since 1998, I have been the Director of Pediatric Radiation Oncology on the MSK Kids team who cares for children and young adults with cancer. I am a member of the pediatric, ophthalmic, and bone marrow transplant disease management teams at MSK and work very closely with surgeons and medical oncologists in these specialties.
I have extensive experience treating rare diseases in young people such as sarcomas, brain tumors, neuroblastoma, Wilms’ tumor, lymphoma, and leukemia. Radiation therapy is an extremely powerful tool for these tumors, but young patients are especially sensitive to long-term side effects. I therefore approach each patient as a unique individual, carefully designing a highly customized radiation therapy plan to maximize the benefits of treatment while minimizing side effects. I am a leader in the use of targeted approaches such as proton therapy, intensity-modulated radiation therapy, image-guided radiation therapy, and intra-operative radiation therapy for pediatric cancers.
In the Brain Tumor Center, I treat all children and teenagers with cancers of the brain and spinal cord (central nervous system). My clinical research has led to changes in our approach to the treatment of tumors such as medulloblastoma and central nervous system germ cell tumors. We are very mindful of patients’ long-term quality of life and seek to maintain the highest possible survival rates while minimizing the risk of potential long-term treatment complications.
I am involved in numerous clinical trials and oversee large international studies for the Children’s Oncology Group in the areas of soft-tissue sarcoma and Hodgkin lymphoma. I am involved with research on the late effects of radiation therapy through my collaboration with the Childhood Cancer Survivor Study.
I find it very rewarding to work with a team that couples extraordinary experience with compassion to care for patients with cancer. I am optimistic that our ongoing research will lead to higher cure rates as well as improved long-term quality of life for our patients.
I have extensive experience treating rare diseases in young people such as sarcomas, brain tumors, neuroblastoma, Wilms’ tumor, lymphoma, and leukemia. Radiation therapy is an extremely powerful tool for these tumors, but young patients are especially sensitive to long-term side effects. I therefore approach each patient as a unique individual, carefully designing a highly customized radiation therapy plan to maximize the benefits of treatment while minimizing side effects. I am a leader in the use of targeted approaches such as proton therapy, intensity-modulated radiation therapy, image-guided radiation therapy, and intra-operative radiation therapy for pediatric cancers.
In the Brain Tumor Center, I treat all children and teenagers with cancers of the brain and spinal cord (central nervous system). My clinical research has led to changes in our approach to the treatment of tumors such as medulloblastoma and central nervous system germ cell tumors. We are very mindful of patients’ long-term quality of life and seek to maintain the highest possible survival rates while minimizing the risk of potential long-term treatment complications.
I am involved in numerous clinical trials and oversee large international studies for the Children’s Oncology Group in the areas of soft-tissue sarcoma and Hodgkin lymphoma. I am involved with research on the late effects of radiation therapy through my collaboration with the Childhood Cancer Survivor Study.
I find it very rewarding to work with a team that couples extraordinary experience with compassion to care for patients with cancer. I am optimistic that our ongoing research will lead to higher cure rates as well as improved long-term quality of life for our patients.
Research Interests
Papers共 476 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PEDIATRIC BLOOD & CANCERno. 6 (2024): e30949-e30949
Abha A Gupta, Wei Xue, Douglas J Harrison,Douglas S Hawkins, Roshni Dasgupta,Suzanne Wolden,Barry Shulkin, Amira Qumseya, Jonathan C Routh,Tamara MacDonald, Shari Feinberg, Brian Crompton,
The Lancet. Oncologyno. 7 (2024): 912-921
Karthik Kanagaraj, Michelle A. Phillippi, Pratyush Narayan, Barbara Szolc,Jay R. Perrier,Amanda Mclane,Suzanne L. Wolden, Christopher A. Barker,Qi Wang,Sally A. Amundson,David J. Brenner,Helen C. Turner
CYTOGENETIC AND GENOME RESEARCHno. 3-4 (2024): 121-130
Practical Radiation Oncologyno. 3 (2024): e226-e232
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEno. 6 (2024): 885-894
PEDIATRIC BLOOD & CANCERno. 5 (2024): e30929-e30929
Urvish Jain, Angelin Mathew, Bhav Jain, Erin Jay Garbes Feliciano, Edward Christopher Christopher Dee,Suzanne L. Wolden
Journal of Clinical Oncologyno. 16_suppl (2024): 1591-1591
Journal of cancer survivorship : research and practicepp.1-8, (2023)
International journal of radiation oncology, biology, physicsno. 2 (2023): S77-S77
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn